NCT02805127

Brief Summary

This is an observational study which aims to evaluate the possibility of using data from a capnography device to assess obstructive airway severity in both Chronic Obstructive Pulmonary Disease (COPD) and Asthma patients.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2016

Shorter than P25 for all trials

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 17, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

December 22, 2016

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 6, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 6, 2017

Completed
Last Updated

December 8, 2017

Status Verified

December 1, 2017

Enrollment Period

8 months

First QC Date

June 15, 2016

Last Update Submit

December 6, 2017

Conditions

Keywords

AsthmaCOPDCapnography

Outcome Measures

Primary Outcomes (1)

  • Correlation between capnography parameters and severity of asthma

    Correlation between the airway obstruction severity calculation based on the capnography parameters and the clinical severity of asthma and COPD as defined by forced expiratory volume in 1 second (FEV1), in severe asthma and COPD patients

    1/2 hour to 48 hours from enrollment of subjects

Study Arms (1)

Patients with COPD and Asthma .

Patients with COPD and Asthma. Continuous capnography and spirometry measurements of the subjects will be taken form the subjects with at least two minutes recording before the first spirometry assessment. All clinical diagnoses and treatments will be performed according to the department's protocols. This is an observational study with no interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Asthma and COPD patients

You may qualify if:

  • Age \>18
  • Ability and willingness to participate the study and sign informed consent form
  • Asthma / COPD patients

You may not qualify if:

  • Pregnant women
  • Asthma or COPD patients with FEV1 \> 60%
  • Disability or unwillingness to undergo capnography measurement
  • Cannot be assessed for FEV1
  • Oxygen supply \>5 L/min

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ruth Stalnikowicz, Prof. ; M.D.

    Emergency Department, Hadassah University Hospital Mount Scopus

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2016

First Posted

June 17, 2016

Study Start

December 22, 2016

Primary Completion

August 6, 2017

Study Completion

August 6, 2017

Last Updated

December 8, 2017

Record last verified: 2017-12

Data Sharing

IPD Sharing
Will not share